Refine by
Animal Health Articles & Analysis
53 news found
Since 2020-2021, H5N1 2.3.4.4b clade viruses have become widespread in wild birds worldwide, leading to outbreaks in poultry and other animals. In the spring of 2024, H5N1 2.3.4.4b clade viruses have also been detected in milk samples from cows and in raw milk in several states in the United States, causing significant global concern due to their serious impact on poultry and ...
The move is poised to elevate the standard and efficacy of veterinary pharmaceuticals, reinforcing CD Formulation’s dedication to the well-being of animals globally. “Our extensive portfolio covers a range of pharmacological services essential for the intricate process of veterinary drug development. ...
CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...
The company's veterinary product line represents its dedication to addressing the unique needs of the animal health industry.Fluralaner, one of the flagship products in Huateng Pharma's veterinary portfolio, is a highly effective API used in the treatment and prevention of various parasitic infections in animals. ...
Dyadic is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products and alternative proteins for human and animal health. bYoRNA is a French biotechnology company focused on producing ...
Funds to support scale-up, including continued development of AI-augmented knowledge discovery platform, the e[datascientist]™, and continued international expansion Platform business focused on bridging the current ‘translation gap’, addressing critical bottlenecks in the industrial application of microbiome science – from soil, to plant, to farm, to fork, to human, ...
RevBio, Inc., announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of vertebral compression fractures with its patented bone adhesive technology known as Tetranite®. ...
The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com. About LightDeck Diagnostics LightDeck Diagnostics believes in a new approach to healthcare, where quick and accurate diagnostic tests will be run wherever and whenever ...
Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces the launch of its new B2C e-commerce website, abingdonsimplytest.com. ...
Since then, ANGANY’s platform has attracted significant attention from major players in the Pharma and Animal Health markets. Based on this interest and following a successful Series A round of $ 15 million backed exclusively by private investors, ANGANY is currently preparing a Series B investment round of $ 35 million to finance upcoming clinical ...
The company will refocus on its animal health division while it evaluates its future opportunities for its human division and subsidiary. ...
“At DePuy Synthes, we look at innovation with one goal in mind: to bring differentiated solutions to market to address the unmet needs of surgeons and patients around the world,” said Oray Boston***, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial and Animal Health. “Healthy feet are a foundational element of overall ...
Trilla connects two vastly disparate fields of health and business. After a career that included service inside various pharmaceutical companies, Dr. Trilla founded Trifermed in 2002, a business service provider specializing in orchestrating worldwide partnerships for health solutions (including corporate strategy, business development, fundraising, among ...
(OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions will take steps to relaunch its veterinary division to tackle animal health innovation. U.S. Stem Cell’s longstanding animal division, Vetbiologics, has for years provided the Veterinary field with ...
Epica International, a leader in cutting-edge mobile medical imaging systems and precision manufacturing robotics, unveiled their new headquarters and operations facility in Duncan on Thursday, May 13. The 27,000-square-foot headquarters, warehousing and assembly facility is located in The Spark Center on Spartanburg Community College’s Tyger River campus. Dr. Randy Axelrod, Epica CEO, ...
Imbed Biosciences is proud to announce that its animal health product, MicroLyte® Vet, is now available in Canada through McCarthy and Sons Service. ...
The company will refocus on its animal health division while it evaluates its future opportunities for its human division and subsidiary. ...
SPARTANBURG, SC – MAY 13, 2021 – Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. WHAT: Epica International, with offices in San ...
Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. What: Epica International, with offices in San Clemente, California and manufacturing and ...
The results showed that a novel solid-dose ImplaVax® formulation of a recombinant E2 antigen CSF virus vaccine delivered subcutaneously using the ImplaVax® needle-free injection device generated a stronger immune response than standard liquid CSF vaccine formulations, particularly in terms of CSF virus-specific T-cell responses. CSF is a significant animal ...